TOX3 (TOX high mobility group box family member 3) is a transcriptional coactivator that regulates diverse cellular processes through chr16 binding and transcriptional activation. The protein functions as a transcriptional driver for hepatic glucose production by directly binding to and activating the FoxO1 promoter, thereby stimulating gluconeogenesis 1. TOX3 demonstrates tissue-specific regulatory roles, with altered methylation patterns and expression levels observed in polycystic ovarian syndrome, where decreased TOX3 protein levels correlate with disease pathology 2. The gene also appears to influence cellular differentiation, as TOX3 expression changes are associated with selection against goblet cell differentiation in colorectal cancer through methylation alterations rather than mutations 3. Clinically, TOX3 polymorphisms, particularly rs3803662 C>T, rs12443621 A>G, and rs8051542 C>T, are significantly associated with increased breast cancer risk across multiple populations, with meta-analysis of 97,275 cases and 128,686 controls confirming these associations 4. The rs3803662 polymorphism shows particular relevance in breast cancer susceptibility, with T alleles conferring increased risk and associations with specific receptor subtypes including progesterone receptor-positive and triple-negative breast cancers 5. These findings establish TOX3 as a metabolically relevant transcription factor with important implications for cancer susceptibility and metabolic disease.